13107 results about "Tissue culture" patented technology

According to the invention, there is provided seed and plants of the corn variety designated I285291. The invention thus relates to the plants, seeds and tissue cultures of the variety I285291, and to methods for producing a corn plant produced by crossing a corn plant of variety I285291 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety I285291 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety I285291.

According to the invention, there is provided seed and plants of the corn variety designated I351729. The invention thus relates to the plants, seeds and tissue cultures of the variety I351729, and to methods for producing a corn plant produced by crossing a corn plant of variety I351729 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety I351729 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety I351729.

A nanofibrillar structure for cell culture and tissue engineering is disclosed. The nanofibrillar structure can be used in a variety of applications including methods for proliferating and/or differentiating cells and manufacturing a tissue. Also disclosed is an improved nanofiber comprising a lipid, lipophilic molecule, or chemically modified surface. The nanofibers can be used in a variety of applications including the formation of nanofibrillar structures for cell culture and tissue engineering.

The present invention relates to a method for isolating stem/progenitor cells from the amniotic membrane of umbilical cord, wherein the method comprises separating the amniotic membrane from the other components of the umbilical cord in vitro, culturing the amniotic membrane tissue under conditions allowing cell proliferation, and isolating the stem/progenitor cells from the tissue cultures. The isolated stem cell cells can have embryonic stem cell-like properties and can be used for various therapeutic purposes. In one embodiment, the invention relates to the isolation and cultivation of stem cells such as epithelial and/or mesenchymal stem/progenitor cells under conditions allowing the cells to undergo mitotic expansion. Furthermore, the invention is directed to a method for the differentiation of the isolated stem/progenitor cells into epithelial and/or mesenchymal cells.

The invention provides seed and plants of the lettuce line designated PS 06518893. The invention thus relates to the plants, seeds and tissue cultures of lettuce line PS 06518893, and to methods for producing a lettuce plant produced by crossing a plant of lettuce line PS 06518893 with itself or with another lettuce plant, such as a plant of another line. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of a plant of lettuce line PS 06518893, including the gametes of such plants.

According to the invention, there is provided seed and plants of the corn variety designated CV847814. The invention thus relates to the plants, seeds and tissue cultures of the variety CV847814, and to methods for producing a corn plant produced by crossing a corn plant of variety CV847814 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety CV847814 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety CV847814.

The present invention provides defined serum-free cell culture media useful in culturing fibroblasts, especially articular chondrocytes, that avoids problems inherent in the use of serum-containing media. The defined media comprise platelet-derived growth factor (PDGF), and chemically defined lipids, or combinations of these compounds. In another aspect, the present invention also provides tissue culture methods that comprise incubating chondrocytes in the defined serum free media. The methods enhance attachment and proliferative expansion of chondrocytes seeded at low density while maintaining their redifferentiation potential.

According to the invention, there is provided seed and plants of the corn variety designated I226218. The invention thus relates to the plants, seeds and tissue cultures of the variety I226218, and to methods for producing a corn plant produced by crossing a corn plant of variety I226218 with itself or with another corn plant, such as a plant of another variety. The invention further relates to corn seeds and plants produced by crossing plants of variety I226218 with plants of another variety, such as another inbred line. The invention further relates to the inbred and hybrid genetic complements of plants of variety I226218.

According to the invention, there is provided seed and plants of the hybrid corn variety designated CH093858. The invention thus relates to the plants, seeds and tissue cultures of the variety CH093858, and to methods for producing a corn plant produced by crossing a corn plant of variety CH093858 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH093858.

According to the invention, there is provided seed and plants of the hybrid corn variety designated CH041570. The invention thus relates to the plants, seeds and tissue cultures of the variety CH041570, and to methods for producing a corn plant produced by crossing a corn plant of variety CH041570 with itself or with another corn plant, such as a plant of another variety. The invention further relates to genetic complements of plants of variety CH041570.

A method for preparing a tissue culture insert that is used for constructing a transplantable graft of an engineered tissue equivalent comprising living main functional cells, stromal cells and tissue matrix on/in a biological supporting membrane for treatment of body tissue defects.

The invention relates to a bioreactor comprising a chamber for containing cells or tissue cultures within a culture medium. The bioreactor also comprises a detector capable of detecting a change in one or more metabolites associated with growth of the cell or tissue cultures within the chamber and a chamber drive capable of rotating the chamber at a first speed about a first axis and a second speed about a second axis, the second axis being disposed at an angle relative to the first axis. In use, the magnitude of the first speed and the second speed are independently variable of each other.

A tissue culture vessel includes opposed top and bottom walls and sidewalls extending between the top and bottom walls. The top wall is formed with a septum aperture and a resealable septum is mounted in the septum aperture to permit access to interior regions of the tissue culture vessel by a medical device for accessing tissue grown in the vessel. The top wall may also include a membrane aperture and a membrane may be mounted in the membrane aperture for providing gas communication to interior portions of the tissue culture vessel.